Pancreatic Cancer Research

ResearcherStavanger University HospitalActive in the last 2 years

Marcus T. T. Roalsø

Matched on ORCID iD 0000-0002-4689-4412; OpenAlex author ID A5051003528. Sources: OpenAlex.

Their work

Papers
8 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2020: 2 papers · 2021: none · 2022: 2 papers · 2023: 1 paper · 2024: none · 2025: 3 papers

Papers 8

  1. Patient-derived organoids from pancreatic cancer after pancreatectomy: Feasibility and organoid take rate in treatment-naïve periampullary tumors. Co-author DOI 10.1016/j.pan.2024.12.018↗
  2. A decade of patient-derived organoids in pancreatic cancer: points in translation. Co-author DOI 10.1080/00365521.2025.2555701↗
  3. Long-term Outcomes Following Resection of Adenocarcinoma Arising from Intraductal Papillary Mucinous Neoplasm (A-IPMN) Versus Pancreatic Ductal Adenocarcinoma … Co-author DOI 10.1097/sla.0000000000006272↗
  4. Early Diagnosis of Pancreatic Cancer: Clinical Premonitions, Timely Precursor Detection and Increased Curative-Intent Surgery. Co-author DOI 10.1177/10732748231154711↗
  5. The prognostic relevance of examined lymph nodes for accurate staging of resected pancreatic adenocarcinoma. First author DOI 10.21037/hbsn-2022-14↗
  6. Emerging Role of Epigenetic Alterations as Biomarkers and Novel Targets for Treatments in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3390/cancers14030546↗
  7. Refined TNM-staging for pancreatic adenocarcinoma - Real progress or much ado about nothing? Co-author DOI 10.1016/j.ejso.2020.02.014↗
  8. Is There a Trojan Horse to Aggressive Pancreatic Cancer Biology? A Review of the Trypsin-PAR2 Axis to Proliferation, Early Invasion, and Metastasis. First author DOI 10.1089/pancan.2019.0014↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Kjetil Søreide · 7 shared papers, 2020–2025 · strength 1.79
  2. Claudia Zaharia · 3 shared papers, 2022–2025 · strength 0.77
  3. Daniel Öhlund · 1 shared paper, 2025 · strength 0.42
  4. Jan Rune Aunan · 2 shared papers, 2020 · strength 0.38
  5. Hanne Røland Hagland · 1 shared paper, 2025 · strength 0.27
  6. Jacob Ghotbi · 1 shared paper, 2023 · strength 0.24

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.